Maddoflox (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By preventing these enzymes from resealing DNA strands, the drug causes bacterial DNA breakage, leading to cell death and a bactericidal effect against a broad range of Gram‑negative and Gram‑positive bacteria.

The dosage of Maddoflox is determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Only a qualified health professional can set the appropriate dose and treatment duration.

Levofloxacin is generally avoided during pregnancy and lactation unless the potential benefit outweighs the risk, as safety data are limited. Healthcare providers should evaluate the risk‑benefit profile for each patient and consider alternative agents when possible.

To order Maddoflox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Maddoflox (levofloxacin) offers broad‑spectrum coverage and once‑daily dosing, which can be advantageous over some beta‑lactams that require multiple daily doses. However, fluoroquinolones carry specific safety considerations, such as tendon risk and QT prolongation, that may make other classes preferable in certain patients.

Maddoflox tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture, excessive heat, and direct sunlight to maintain potency throughout its shelf life.

Maddoflox is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminum or magnesium, as these may reduce absorption. Follow the prescribing clinician’s instructions for timing and duration.

Serious risks include tendon rupture, especially in the Achilles tendon, QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare cases of hepatic toxicity or peripheral neuropathy. Patients should report any concerning symptoms promptly.

Maddoflox should not be used by individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones. Caution is advised for patients with a history of tendon disorders, cardiac arrhythmias, or those taking medications that prolong the QT interval. The drug is also contraindicated in certain pediatric populations unless specifically indicated.